Wealth Enhancement Advisory Services, LLC Sutro Biopharma, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 21,201 shares of STRO stock, worth $24,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,201
Previous 17,199
23.27%
Holding current value
$24,381
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.1MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$7.95 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$7.46 Million0.16% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$5.85 Million0.43% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$5.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$4.73 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $60M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...